Controversies and Conundrums in the Treatment of Community-acquired Bacterial Pneumonia (Part 2 of 3)

ASHP Advantage's Engaging the Experts
20/06/2014 12 min
Controversies and Conundrums in the Treatment of Community-acquired Bacterial Pneumonia (Part 2 of 3)

Listen "Controversies and Conundrums in the Treatment of Community-acquired Bacterial Pneumonia (Part 2 of 3)"

Descargar episodio Ver en sitio original

Episode Synopsis



More episodes of the podcast ASHP Advantage's Engaging the Experts

Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma 28/04/2020
Strategies for Prevention and Treatment of Recurrent C. difficile Infection 28/04/2020
Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance 22/07/2019
Revised USP Chapter 797 (Part 2): Getting Your Facility Ready 22/07/2019
Revised USP Chapter <797> (Part 1): Overview of Changes 22/07/2019
Integrating Gene Therapies into Pharmacy Practice 18/01/2019
Biosimilars: Focus on Interchangeability and Integration into the Medication-use System (Part 2 of 2) 05/02/2016
Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile 26/04/2017
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2) 28/02/2017
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2) 28/02/2017
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA